Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis

Published:2014-06-11 Issue:9 Volume:35 Page:9095-9100
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Zhang Shengli,Fang Jianzheng,Zhang Xiangxiang,Qin Chao,Su Shifeng,Deng Yunfei,Song Zhen,Zhang Yi,Wang Hainan,Yin Changjun,Wang Zengjun

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-014-2184-6.pdf

Reference22 articles.

1. Li Z, Zhang Y, Kim WJ, et al. PGE2 promotes renal carcinoma cell invasion through activated RalA. Oncogene. 2013;32:1408.

2. Sun M, Lughezzani G, Perrotte P, et al. Treatment of metastatic renal cell carcinoma. Nat Rev Urol. 2010;7:327.

3. Negrier S. Duration of targeted therapy for metastatic renal cell carcinoma: a review of current practices. Oncology. 2012;82:189.

4. Cairns P. Renal cell carcinoma. Cancer Biomark. 2010;9:461.

5. Canacci AM, Izumi K, Zheng Y, et al. Expression of semenogelins I and II and its prognostic significance in human prostate cancer. Prostate. 2011;71:1108.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of SEMG1 overexpression in OSCC tumorigenesis and its relation with metabolic molecules;Oral Diseases;2024-08-18

2. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer;Cancer Genomics - Proteomics;2023

3. Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells;Cell Death Discovery;2021-05-08

4. SEMG1/2 augment energy metabolism of tumor cells;Cell Death & Disease;2020-12

5. Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells;Cell Death Discovery;2020-10-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3